Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Monday's Intraday Session

Author: Benzinga Insights | October 30, 2023 01:30pm

Gainers

  • Miromatrix Medical (NASDAQ:MIRO) shares increased by 217.2% to $3.3 during Monday's regular session. The current volume of 2.9 million shares is 15262.3% of Miromatrix Medical's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $90.0 million.
  • Eargo (NASDAQ:EAR) stock moved upwards by 52.38% to $2.56. Trading volume for Eargo's stock is 3.0 million as of 13:30 EST. This is 8069.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $53.1 million.
  • Reviva Pharmaceuticals (NASDAQ:RVPH) stock increased by 43.25% to $5.37. Trading volume for this security as of 13:30 EST is 28.1 million, which is 15724.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $121.6 million.
  • Motus GI Hldgs (NASDAQ:MOTS) shares increased by 35.65% to $0.56. The current volume of 9.0 million shares is 5804.7% of Motus GI Hldgs's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $3.2 million.
  • BioXcel Therapeutics (NASDAQ:BTAI) shares moved upwards by 25.88% to $3.81. BioXcel Therapeutics's stock is trading at a volume of 11.1 million shares as of 13:30 EST. This is 435.7% of its average full-day volume over the last 100 days. The company's market cap stands at $111.6 million.
  • VYNE Therapeutics (NASDAQ:VYNE) shares rose 25.24% to $2.81. As of 13:30 EST, this security is trading at a volume of 18.6 million shares, making up 117219.3% of its average full-day volume over the last 100 days. The company's market cap stands at $9.2 million.

Losers

  • LumiraDx (NASDAQ:LMDX) shares declined by 27.2% to $0.09 during Monday's regular session. As of 13:30 EST, this security is trading at a volume of 14.9 million shares, making up 250.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $27.8 million.
  • Qualigen Therapeutics (NASDAQ:QLGN) shares decreased by 22.86% to $0.66. The company's market cap stands at $3.3 million.
  • Tenax Therapeutics (NASDAQ:TENX) shares declined by 20.95% to $0.2. Trading volume for Tenax Therapeutics's stock is 1.1 million as of 13:30 EST. This is 239.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $4.7 million.
  • Better Therapeutics (NASDAQ:BTTX) stock declined by 16.59% to $0.15. Trading volume for this security as of 13:30 EST is 1.7 million, which is 114.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $6.2 million.
  • ABVC BioPharma (NASDAQ:ABVC) shares decreased by 15.94% to $1.16. The current volume of 2.7 million shares is 152.6% of ABVC BioPharma's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $4.5 million.
  • Biotricity (NASDAQ:BTCY) stock declined by 15.83% to $1.17. Trading volume for this security as of 13:30 EST is 55.1K, which is 211.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $10.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ABVC BTAI BTCY BTTX EAR LMDX MIRO MOTS QLGN RVPH TENX VYNE

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist